Abstract
Bariatric surgery (BS) is a surgical intervention that aims to reduce excess body weight and improve obesity-related comorbidities. Obesity is a growing health problem among patients with human im¬munodeficiency virus (HIV) infection, especially with the widespread use of antiretroviral therapy (ART). However, there is limited evidence on the safety and efficacy of bariatric surgery in this pop¬ulation. This review summarizes the current knowledge on bariatric surgery in HIV patients, focusing on the types of procedures, the impact on HIV-related outcomes, antiretroviral considerations, concerns, and possible complications. The available data suggest that bariatric surgery is safe and well tolerated in HIV-infected individuals and does not adversely affect HIV disease progression or virologic suppression. However, bariatric surgery may increase the risk of postoperative complications such as strictures and micronutrient deficiencies and may require adjustments in ART regimens due to altered pharmacokinetics. Therefore, careful selection of candidates, multidisciplinary collaboration, and close monitoring are essential for optimal outcomes. Further studies are needed to evaluate the long-term effects of bariatric surgery in HIV patients and to compare different surgical techniques.

Key words: Bariatric surgery, HIV infection, Obesity, Antiretrovirals, People living with HIV